Refine your search
Collections
Co-Authors
Journals
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Duragkar, N. J.
- Contribution of Traditional Medicines to the Development of Modern Medicine for Malaria
Abstract Views :291 |
PDF Views:2
Authors
Affiliations
1 Sharad Pawar College of Pharmacy, Wanadongri, Hingna Road, Nagpur- 441 110 (M.S.), IN
1 Sharad Pawar College of Pharmacy, Wanadongri, Hingna Road, Nagpur- 441 110 (M.S.), IN
Source
Research Journal of Pharmacology and Pharmacodynamics, Vol 3, No 1 (2011), Pagination: 1-4Abstract
Malaria is caused by protozoan parasites of the genus Plasmodium. The most serious forms of the disease are caused by Plasmodium falciparum and Plasmodium vivax, but other related species (Plasmodium ovale, Plasmodium malariae) can also affect humans. The initial symptoms of malaria which include fever, headache and muscular aches. Plasmodium develops in the gut of the mosquito and passed in the saliva of an infected insect each time it takes a new blood meal. The parasites are then carried by the blood in the victim's liver where they invade the cells and multiply. After 9-16 days they return to the blood and penetrate the red cells, where they multiply again, progressively breaking down the red cells. In cerebral malaria, the infected red cells obstruct the blood vessels in the brain. The four species of malaria are distinguished by their different appearances of Trophozoites, Schizonts, Gametocytes and staining, size and shape of infected red blood cells, and other characteristics. The key role of traditional medicine in the development of modern medicine for prevention of malaria is discussed in this article. In-vitro and in-vivo antiplasmodial activities are experimental models for detecting antiplasmodial activity of plant extracts in the erythrocytic stage of malaria parasites. The study is likely to promote a rational use of botanicals and must be continued focusing on the isolation and characterizing active principles of the crude extract, its pharmacological validation, standardization and formulation.Keywords
Malaria, Plasmodium falciparum, Antiplasmodial Activity.References
- Cox F. History of human parasitology. Clinical Microbiol Rev. 2002; 15 (4): 595-612.
- Breman J. The ears of hippopotamus: manifestations, determinants and estimates of the malarial burden. Am J Trop Med Hyg. 2001; 64 (1-2): 1-11.
- Greenword BM, Bojang K, Whitty CJ and Targett GA. Malaria. Lancet. 2005; 365: 1487-1498.
- Van Benthem B, Vanwambeke S, Khantikul N, Burghoorn-Mass C, Panart K, Oskam L, Lambin E and Samboon P. Spatial patterns of and risk factors for seropositivity for dengue infection. Am J Trop Med Hyg. 2005; 72(2): 201-208.
- http://www.ciisocialcouncil.org
- http://www.health.sa.gov.au
- Foley M and Tilley L. Quinoline antimalarials: Mechanism of action and resistance and prospects for new agents. Pharmacol Ther. 1998; 79: 55-87.
- http://www.textbooksonline.tn.nic.in
- http://www.malaria.org.za
- Tinto H, Rwagacondo C and Karema C. In-vitro suceptibility of Plasmodium falciparum to monodesethylamodiaquine, dihydroartemisin and quinine in an area of high chloroquine esistance in Rwand. Trans R Soc Trop Med Hyg. 100 (6): 509-514.
- Ridley RG. Medical need, scientific opportunity and drive for antimalarial drugs. Nature. 2002; 415: 686-693.
- Ronn AM, Msangeni HA, Mhina J, Wernsdorfer WH and Bygbjerg IC. High level of resistance of P. falciparum to sulfadoxime-pyrimethamine in children in Tanzania. Trans R Soc Trop Med Hyg. 1996; 90: 179-181.
- Sowunmi A, Oduola AM, Ogundahunsi OA and Salako LA. Comparitive efficacy of chlroquine plus chlorophenaramine and pyrimethamina/sulfadoxine in acute uncomplicated falciparum malaria in Nigerian children. Trans R Soc Trop Med Hyg. 1998; 92: 77-81.
- White NJ. Drug resistance in malaria. Br Med Bull. 1998. 54: 703-715.
- Foote SJ and Cowman AF. The mode of action and the mechanism of resistance to antimalarial drugs. Acta Trop. 1994; 56: 157-171.
- Ward SA, Bray BG, Mungthin M and Hawley SR. Current views on the mechanism of resistance to quinoline containing drugs in P. falciparum. Ann Trop Med Parasitol. 1995; 89: 121-124.
- Chawira AN and Warhurst DC. The effect of Artemisinin combined with standard antimalarils against chloroquine sensitive and chloroquine resistant strains of P. falciparum invitro. J Trop med Hyg. 1987; 90: 1-8.
- Olliaro PL and Trigg PI. Status of antimalarial drugs under development. Bull World Health Organ. 1995; 73: 565-571.
- Willcox M and Bodeker G. An Overview of Ethnobotonical Studies on Plants Used for the treatment of Malaria. In Merlin Willcox, Gerard Bodeker and Philippe Rasoanaivo's. Traditional medicinal Plants and Malaria. CRC Press, London.
- Review Article on Gene Therapy
Abstract Views :397 |
PDF Views:2
Authors
Affiliations
1 Modern College of Pharmacy, Sector 21, Yamunanagar, Nigdi, Pune-44 (M.S), IN
2 Sharad Pawar College of Pharmacy, Nagpur, IN
1 Modern College of Pharmacy, Sector 21, Yamunanagar, Nigdi, Pune-44 (M.S), IN
2 Sharad Pawar College of Pharmacy, Nagpur, IN
Source
Research Journal of Pharmacology and Pharmacodynamics, Vol 4, No 2 (2012), Pagination: 77-83Abstract
Gene therapy can be broadly defined as the transfer of genetic material to cure a disease or at least to improve the clinical status of a patient. One of the basic concepts of gene therapy is to transform viruses into genetic shuttles, which will deliver the gene of interest into the target cells. Based on the nature of the viral genome, these gene therapy vectors can be divided into RNA and DNA viral vectors. The majority of RNA virus-based vectors have been derived from simple retroviruses like murine leukemia virus. A major shortcoming of these vectors is that they are not able to transducer nondividing cells. This problem may be overcome by the use of novel retroviral vectors derived from lentiviruses, such as human immunodeficiency virus (HIV). The most commonly used DNA virus vectors are based on adenoviruses and adeno-associated viruses. An example of gene-knockout mediated gene therapy is the knockout of the human CCR5 gene in T-cells in order to control HIV infection. Although the available vector systems are able to deliver genes in vivo into cells, the ideal delivery vehicle has not been found. Thus, the present viral vectors should be used only with great caution in human beings and further progress in vector development is necessary.Keywords
Lentiviruses, Transducer, RNA Vector, Adeno-Associated Viruses.References
- Perez EE, Wang J, Miller JC, "Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc finger nucleases". Nat. Biotechnol. 808–16 (July 2008).
- Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD "Genome editing with engineered zinc finger nucleases". 636– 46(September 2010).
- Durai S, Mani M, Kandavelou K, Wu J, Porteus MH, Chandrasegaran S "Zinc finger nucleases: custom-designed molecular scissors for genome engineering of plant and mammalian cells". Nucleic Acids Res. 33 ,5978–90. "The Process of Gene Therapy." Alternate Heals. 8 may 2006. Alternate Medicine (23 November 2009).
- Harwood, Adrian J. Protocols for Gene Analysis. 1st. 31. Totowa, New Jersey: Humana Press, Friedmann, T.; Roblin, R "Gene Therapy for Human Genetic Disease?". Science 175 (25): 949 (1972).
- Alvarez-Erviti L, Seow Y, Yin HF et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes., Published online March 20 (2011).
- Wrobel, I. and Collins, D. Fusion of cationic liposomes with mammalian cells occurs after endocytosis. Biocim. Biophys. Acta 1235, 296–304(1995).
- Woods NB, Bottero V, Schmidt M, von Kalle C, Verma IM "Gene therapy: therapeutic gene causing lymphoma". Nature 440 ,7088 (Apr 2006).
- Wang, Hongjie; Dmitry M. Shayakhmetov, Tobias Leege, Michael Harkey, Qiliang Li, Thalia Papayannopoulou, George Stamatoyannopolous, and Andre Lieber "A capsid-modified helper-dependent adenovirus vector containing the beta-globin locus control region displays a nonrandom integration pattern and allows stable, erythroid-specific gene expression". Journal of Virology 79 (17): 10999–101(September 2005).
- Gao, X. and Huang, L. Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry 35,1027(1996) .
- Horn PA, Morris JC, Neff T, Kiem HP "Stem cell gene transfer - efficacy and safety in large animal studies". Mol. Ther. 10 (3): 417–31.(Sep 2004).
- Jenkins, R. G., Meng, Q. H., Hodges, R. J., Lee, L. K., Bottoms, S. E. W., Laurent, G.J.,Willis, D., Ayazi Shamlou, P., McAnulty, R. J. and Hart, S. L. Farhood, H., Serbina, N. and Huang, L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim. Biophys. Acta 1235, 289–295 (1995)
- Chen, Q.-R., Zhang, L., Stass, S. A. and Mixson, A. J. Copolymer of histidine and lysine markedly enhances transfection efficiency of liposomes. Gene Ther. (2000)
- Duguid, J. G., Li, C., Shi, M., Logan, M. J., Alila, H., Rolland, A., Tomlinson, E., Sparrow, J. T. and Smith, L. C. A physiochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy. Biophys. J. 74, 2802–2814(1998).
- Brown, M. D., Schatzlein, A. G. and Uchegbu, I. F. Gene delivery with synthetic (non viral) carriers. Int. J. Pharm. 229, 1–21(2001)
- Tachibana, R., Harashima, H., Shinohara, Y. and Kiwada, H. Quantitative studies on the nuclear import of plasid DNA and gene expression employing non-viral vectors. Adv. Drug Delivery Rev. 52, 219–226(2001)
- Auton, C. W. Nuclear import of polypeptides, polynucleotides and supramolecular complexes. Adv. Drug. Delivery Rev. 34, 51–64(1998)
- Formulation and Evaluation of Antidiabetic Herbal Capsules
Abstract Views :273 |
PDF Views:0
Authors
Affiliations
1 Sharad Pawar College of Pharmacy, Wanadongari, Hingana Road, Nagpur- 441110 (M. S.), IN
2 Sharad Pawar College of Pharmacy, Wanadongri, Hingna Road, Nagpur-441 110 (MS), IN
1 Sharad Pawar College of Pharmacy, Wanadongari, Hingana Road, Nagpur- 441110 (M. S.), IN
2 Sharad Pawar College of Pharmacy, Wanadongri, Hingna Road, Nagpur-441 110 (MS), IN
Source
Research Journal of Pharmaceutical Dosage Form and Technology, Vol 4, No 2 (2012), Pagination: 113-118Abstract
The work presented here deals with formulation and evaluation of herbal antidiabetic capsule containing dried extracts of Gymnema sylvestre, Mucuna prurience and Ginkgo biloba. Phytochemical screenings of all three extracts were performed and their purity was checked by TLC, HPTLC and also by gravimetric method. While formulating the capsules three batches were selected with different concentration of extracts of Gymnema sylvestre and same quantity of Mucuna prurience and Ginkgo biloba extracts. The antidiabetic activity of three formulations was performed on diabetic rats to find out the better activity than others. The formulation 3 has given the better result as compared to formulation 1 and 2. For the pharmacological evaluation, all the experiments were designed and conducted as per CPCSEA and IAEC guidelines. The single dose study of optimized formulation shows a significant decrease in serum glucose level at 2, 4, 6 and 24 h while comparing with only extract of Gymnema sylvestre and standard antidiabetic drug Glibenclamide. The optimized formulation showed much better result as compared to extract of Gymnema sylvestre. Physical and chemical evaluation of optimized formulation has been performed and compared the peaks of standard drug with extracts and formulation by HPTLC analysis.Keywords
Herbal Capsule, Antidiabetic Activity, Gymnema sylvestre, Mucuna prurience, Ginkgo biloba.- Study of Antimicrobial Activity of Canarium strictum Gum Resin
Abstract Views :239 |
PDF Views:0
Authors
Affiliations
1 Sharad Pawar College of Pharmacy, Wanadongri, Hingna Road, Nagpur- 441100 (M. S.), IN
1 Sharad Pawar College of Pharmacy, Wanadongri, Hingna Road, Nagpur- 441100 (M. S.), IN